Cargando…
晚期非小细胞肺癌表皮生长因子受体基因突变情况和其对吉非替尼疗效的影响
BACKGROUND AND OBJECTIVE: It has been proven that the status of epidermal growth factor receptor (EGFR) gene mutation was related to effects of gefitinib in patients with advanced non-small cell lung cancer (NSCLC). The aim of this study is to reports distribution of EGFR gene mutations in advanced...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
中国肺癌杂志编辑部
2012
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5999860/ https://www.ncbi.nlm.nih.gov/pubmed/22989454 http://dx.doi.org/10.3779/j.issn.1009-3419.2012.09.03 |